Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine for PAH Vasoreactivity (CARVE)
NCT01121458Phase 4Completed
- Sponsor
- VA North Texas Health Care System
- Start
- Sep 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clevidipine in pulmonary arterial hypertension (PAH), sponsored by VA North Texas Health Care System. Primary endpoint: Percent reduction in Pulmonary Vascular Resistance. Started Sep 2009; status: completed.
02
Drugs
clevidipine
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01121458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01121458.